Hong-guang Xie
68 Changle Road
Nanjing, 210006, China
Nanjing, 210006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Hydrogen sulfide replenishment ameliorates impaired platelet response to clopidogrel in mice with experimental diabetes mellitus.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: July 16, 2025
Promising clopidogrel analogs may overcome clopidogrel resistance: 2025 update.
Journal: Biochemical pharmacology
Published: May 11, 2025
Clopidogrel ameliorates high-fat diet-induced hepatic steatosis in mice through activation of the AMPK signaling pathway and beyond.
Journal: Frontiers in pharmacology
Published: September 15, 2024
The metabolic activation of and platelet response to vicagrel vary with P-glycoprotein deficiency, rather than P-glycoprotein inhibition, in mice.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: August 10, 2024
Sex differences in the metabolic activation of and platelet response to vicagrel in mice: Androgen as a key player.
Journal: Biochemical pharmacology
Published: April 22, 2024
The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance.
Journal: Molecular diagnosis & therapy
Published: December 20, 2023
Enhanced metabolic activation of and platelet response to clopidogrel in T cell-deficient mice through induction of Cyp2c and Cyp3a and inhibition of Ces1.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 25, 2022
Vicagrel is hydrolyzed by Raf kinase inhibitor protein in human intestine.
Journal: Biopharmaceutics & drug disposition
Published: July 05, 2022
Choline and trimethylamine N-oxide impair metabolic activation of and platelet response to clopidogrel through activation of the NOX/ROS/Nrf2/CES1 pathway.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 02, 2022
Short-term standard alcohol consumption enhances platelet response to clopidogrel through inhibition of Nrf2/Ces1 pathway and induction of Cyp2c in mice.
Journal: Life sciences
Published: November 30, 2020
P-glycoprotein deficiency enhances metabolic activation of and platelet response to clopidogrel through marked up-regulation of Cyp3a11 in mice: Direct evidence for the interplay between P-glycoprotein and Cyp3a.
Journal: Biochemical pharmacology
Published: September 06, 2020
Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice.
Journal: British journal of pharmacology
Published: June 30, 2020
Last Updated: 09/26/2026